SENSEX NIFTY
May 29, 2013, 07.50 PM IST | Source: CNBC-TV18

Buy Dishman Pharma; may rise by 10-15%: Madan

Ashu Madan, president of core client group at Religare Securities advised buying Dishman Pharma at current levels. In short-term, the stock can go up by 10-15 percent, feels Madan.

Ashu Madan, president of core client group at Religare Securities told CNBC-TV18, " Dishman Pharmaceuticals and Chemicals ' numbers are decent. The way the market movement also suggest I think current price is also a better price or a good price to buy."

“In short-term one might get 10-15 percent return soon. So in any case if somebody can hold it for longer it would be better, but the current price at which it is hovering around is a good price to buy,” Madan said.

Set email alert for

ADS BY GOOGLE

video of the day

Rules of stock-picking: Perils of becoming a fund manager

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.